Skip to main content

Table 4 Survival outcomes of patients with premalignant lesions and cholangiocarcinoma

From: Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area

Diagnosis

Patients with Premalignant lesions

Cholangiocarcinoma patients

Resectable

Unresectable

 

1-year

2-year

1-year

2-year

1-year

2-year

OS

100 %

100 %

75 %

44.4 %

33.3 %

0 %

DFS/PFS

100 %

100 %

100 %

77.8 %

66.7 %

25 %

  1. Abbreviations: OS overall survival, PFS progression free survival, DFS disease free survival